Gene therapy mends wounds in rare 'butterfly skin' disease

NCT ID NCT06892639

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tests a treatment called D-Fi, made from a person's own skin cells that are genetically modified to produce a missing protein. It aims to see if injecting these cells into wounds helps them close completely compared to standard care alone. The trial includes 32 children and adults with dystrophic epidermolysis bullosa, a condition that causes fragile skin and chronic wounds.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary โ€” we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DYSTROPHIC EPIDERMOLYSIS BULLOSA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

dystrophic epidermolysis bullosa, dog epidermolysis bullosa dystrophica

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Children's Hospital Colorado

    Aurora, Colorado, 80045, United States

  • Mission Dermatology

    Santa Margarita, California, 92688, United States

  • Stanford University School of Medicine, Dermatology

    Redwood City, California, 94063, United States

  • University of Massachusetts

    Worcester, Massachusetts, 01655, United States